Citation Impact

1 by Nobel laureates 7 from Science/Nature 58 standout
Sub-graph 1 of 24

Citing Papers

Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial
2023 Standout
GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes
2022 Standout
2 intermediate papers

Works of S. Ross being referenced

Efficacy and safety of empagliflozin twice daily versus once daily in patients with type 2 diabetes inadequately controlled on metformin: a 16‐week, randomized, placebo‐controlled trial
2015
The safety and efficacy of adding once‐daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries
2012

Author Peers

Author EDM Molecular Biology Surgery Last Decade Papers Cites
S. Ross 213 149 106 20 401
Maurizio Memeo 2 9 266 17 567
Axelle Simon 63 428 31 29 1.1k
Liana Hie 1 668 3 19 1.7k
Evert van Imhoff 1 4 29 391
David H. Eccles 1 17 20 645

All Works

Loading papers...

Rankless by CCL
2026